NEOSEV

Description

Composition: Sevelamer Hydrochloride

Product Type: Oral medication in tablet form.

Quantity: 30 tablets per pack.

Strength/Dosage: 400 mg or 800 mg per tablet.

Dosage: Typically prescribed with meals to bind dietary phosphate, as directed by a healthcare provider.

Indications :
Management of Hyperphosphatemia: Used to control high phosphate levels in patients with chronic kidney disease (CKD) on dialysis.
Reduction of Serum Phosphate: Binds dietary phosphate in the gastrointestinal tract, lowering phosphate levels in the blood.
Prevention of Vascular Calcification: Reduces the risk of calcification in blood vessels and soft tissues associated with elevated phosphate levels.
Adjunct Therapy in CKD: Complements dietary phosphate restriction and dialysis in managing hyperphosphatemia.
Improved Bone Health: Helps prevent bone disease and related complications caused by elevated phosphate levels in CKD patients.